CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Bylaws or fiscal year change
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 4 Open-market buy Director bought 40,000 shares at $2.75 ($110,000)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Executive or director change · Other events
- 4/A Grant or award Chief Financial Officer acquired 137,707 shares (grant or award)
- 4/A Grant or award Chief Commercial Officer acquired 247,480 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 250,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 250,000 shares (grant or award)
Page 15 of 33 · 650 filings